video thumbnail

Mixing Vaccine Types - UK Study

Duration: 12:18

Write A New Comment

0 Comments

Mixing Vaccine Types - Oxford University Study

Oxford University is conducting vaccine type mixing for prime dose and the booster dose. In a preliminary data set they have printed the side-effects of mixing the vaccine types. Let’s review the initial reactogenicity data published in Lancet.

Some news: CDC says mask not required for fully vaccinated in certain situations. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html

British airway is trialing highly intelligent 25 seconds saliva based coronavirus test. https://news.sky.com/story/covid-19-ultra-rapid-25-second-coronavirus-test-hailed-as-a-game-changer-in-british-airways-trial-12305272

Now to today’s topic 
Initial reactogenicity data printed in lancet
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01115-6/fulltext

Link with the study protocols
https://comcovstudy.org.uk/study-protocol
Study protocol V5.0
https://comcovstudy.org.uk/files/com-covprotocolv5026-apr-2021finalpdf
Study protocol V2.1
https://comcovstudy.org.uk/files/com-cov2protocolv2123-apr-2021cleanpdf

A study conducted by Oxford University in the UK found that mixing Pfizer-BioNTech and AstraZeneca COVID vaccines had some unexpected results. Let's review the study and its results.

We will discuss:

  1. Study design
  2. Vaccine types included in the study.
  3. Dosage gap and mixing strategy.
  4. The difference in side effects of heterogenous vs. homogenous vaccine doses.
  5. Comparison of the antibody titers with heteregenous vs., homogenous vaccine schedules.

Presented by Dr. Mobeen Syed

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Pharmacology

Related Videos